| 1. | jordanjames7 | |
| 2. | dlrothwell | |
| 3. | wolvergeek | |
| 4. | danielwilliamsms | |
| 5. | 7946manley049 |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | jordanjames7 01/26/2018 Crickets... Nobody? |
| 2. | 7946manley049 01/29/2018 BMY Feb 62 calls are seeing interest with 6970 contracts trading |
| 3. | jordanjames7 01/22/2018 Product expansion |
| 4. | danielwilliamsms 06/04/2018 Announces results from Phase 3 CheckMate -227 |
| 5. | wolvergeek 02/05/2018 Yes, by all means go down so I can buy more |
| 6. | dlrothwell 06/01/2018 Bristol-Myers Opdivo plus low-dose Vervoy |
| 7. | wolvergeek 04/17/2018 Bristol Myers Squibb (BMY) Will Face Significant Headwinds in 2019 - Here's Why |
| 8. | 7946manley049 01/26/2018 $25 Million Payment |
| 9. | wolvergeek 04/17/2018 In CheckMate -141, Opdivo (nivolumab) Demonstrated Sustained Overall Survival (OS) Advantage over Standard of Care in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |
| 10. | jordanjames7 04/16/2018 Announces initial results from pivotal Phase 3 study (CheckMate -227) evaluating Opdivo 3 mg/kg plus low-dose… |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Bristol-Myers Squibb Company
- BMY
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.